BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 6415844)

  • 1. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J; Peake I; Bloom A
    Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
    Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
    J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease.
    Mikami S; Takahashi Y; Nishino M; Okubo Y; Fukui H
    Thromb Haemost; 1981 Jun; 45(3):272-5. PubMed ID: 6792740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of sugar composition of factor VIII/von Willebrand factor in von Willebrand's disease: analysis by crossed affinoimmunoelectrophoresis using lectin (ricinus communis agglutinin-120).
    Mikami S; Ueda M; Yasui M; Takahashi Y; Nishino M; Fukui H
    Thromb Haemost; 1983 Apr; 49(2):87-90. PubMed ID: 6408753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of von Willebrand's disease: study of 40 Iranian cases.
    Shoa'i I; Lavergne JM; Ardaillou N; Obert B; Ala F; Meyer D
    Br J Haematol; 1977 Sep; 37(1):67-83. PubMed ID: 303911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Von Willebrand's syndrome (author's transl)].
    Larrieu MJ; Meyer D; Ardaillou N
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):371-82. PubMed ID: 303357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of factor VIII procoagulant antigen VIII:CAg and factor VIII related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag.
    Tran TH; Duckert F
    Thromb Haemost; 1983 Aug; 50(2):547-51. PubMed ID: 6415848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease.
    Montgomery RR; Zimmerman TS
    J Clin Invest; 1978 Jun; 61(6):1498-507. PubMed ID: 307007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
    Weiss HJ; Sussman II; Hoyer LW
    J Clin Invest; 1977 Aug; 60(2):390-404. PubMed ID: 17621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of factor VIII antigen (VIIIR-Ag) by erythrocyte agglutination].
    Coelho E
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(6):273-6. PubMed ID: 3138751
    [No Abstract]   [Full Text] [Related]  

  • 12. VIIIR; Ag in platelets from patients with various forms of von Willebrand's disease.
    Holmbeg L; Nilsson IM
    Thromb Haemost; 1979 Oct; 42(3):1033-8. PubMed ID: 388718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Von Willebrand's syndrome. Studies on a variant factor VIII.
    Hill FG; Chan MC; Hardisty RM
    Haemostasis; 1976; 5(5):276-84. PubMed ID: 797643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor.
    d'Alessio P; Zwaginga JJ; de Boer HC; Federici AB; Rodeghiero F; Castaman G; Mariani G; Mannucci PM; de Groot PG; Sixma JJ
    Thromb Haemost; 1990 Oct; 64(2):227-31. PubMed ID: 2125373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
    Sultan Y; Simeon J; Caen JP
    J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using a monoclonal antibody to identify patients with type I and type II von Willebrand's disease.
    Hall JD; Willis DW; Evatt BL; Jackson DW
    Thromb Haemost; 1987 Jun; 57(3):332-6. PubMed ID: 3116703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrence of von Willebrand's disease and hemophilia A: implications for carrier detection and prevalence.
    Miller CH; Hilgartner MW; Harris MB; Bussel JB; Aledort LM
    Am J Med Genet; 1986 May; 24(1):83-94. PubMed ID: 3085499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The factor VIII abnormality in severe von Willebrand's disease.
    Zimmerman TS; Abildgaard CF; Meyer D
    N Engl J Med; 1979 Dec; 301(24):1307-10. PubMed ID: 315519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
    Gralnick HR; Coller BS; Sultan Y
    J Clin Invest; 1975 Oct; 56(4):814-27. PubMed ID: 1080491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Von Willebrand's disease: combined qualitative and quantitative abnormalities.
    Gralnick HR; Sultan Y; Coller BS
    N Engl J Med; 1977 May; 296(18):1024-30. PubMed ID: 300468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.